Effects of nonselective and selective cyclooxygenase inhibitors on small intestinal motility in the horse

Research in Veterinary Science

Volumn 86, Issue 1, 2009, Pages 129-135

  Menozzi, A ^a   Pozzoli, C ^a   Poli, E ^a   Dacasto, M ^b   Giantin, M ^b   Lopparelli, R M ^b   Passeri, B ^a   Zullian, C ^a   Gobbetti, T ^a   Bertini, S ^a  

^a UNIVERSITY OF PARMA   (Italy)

^b UNIVERSITY OF PADOVA   (Italy)

Author keywords

Cyclooxygenase 1; Cyclooxygenase 2; Horse; Motility; Nonsteroidal antiinflammatory drugs; Small intestine

Indexed keywords

5 (4 CHLOROPHENYL) 1 (4 METHOXYPHENYL) 3 TRIFLUOROMETHYL 1H PYRAZOLE; 5 BROMO 2 (4 FLUOROPHENYL) 3 (4 METHYLSULFONYLPHENYL)THIOPHENE; CELECOXIB; CYCLOOXYGENASE 1; CYCLOOXYGENASE 1 INHIBITOR; CYCLOOXYGENASE 2; CYCLOOXYGENASE 2 INHIBITOR; DUP 398; FLUNIXIN MEGLUMINE; INDOMETACIN; MESSENGER RNA; N (2 CYCLOHEXYLOXY 4 NITROPHENYL)METHANESULFONAMIDE; NS 697; PROSTAGLANDIN; PROSTAGLANDIN RECEPTOR BLOCKING AGENT; PROSTAGLANDIN SYNTHASE INHIBITOR; UNCLASSIFIED DRUG;

ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DRUG EFFECT; DRUG EFFICACY; DRUG SELECTIVITY; ENTERITIS; GENE EXPRESSION; HISTOLOGY; HORSE; ILEUM; ILEUM MOTILITY; IN VITRO STUDY; INTESTINE CONTRACTION; INTESTINE MOTILITY; MALE; NONHUMAN; NUCLEOTIDE SEQUENCE; PROTEIN DEPLETION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SMALL INTESTINE;

ANIMALS; CLONIXIN; CYCLOOXYGENASE 1; CYCLOOXYGENASE 2; CYCLOOXYGENASE INHIBITORS; GASTROINTESTINAL MOTILITY; HISTOCYTOCHEMISTRY; HORSES; INDOMETHACIN; INTESTINE, SMALL; MALE; PYRAZOLES; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; SULFONAMIDES;

EQUIDAE;

EID: 57749087077     PISSN: 00345288     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.rvsc.2008.04.006     Document Type: Article

References (25)

1. Brideau C., Van Staden C., and Chan C.C. In vitro effects of cyclooxygenase inhibitors in whole blood of horses, dogs and cats. Am. J. Vet. Res. 62 (2001) 1755-1760
2. Dabareiner R.M., and White N.A. Large colon impaction in horses: 147 cases (1985-1991). J. Am. Vet. Med. Assoc. 206 (1995) 679-685
3. Freeman D.E., Inuoue O.J., and Eurell T.E. Effects of flunixin meglumine on short circuit current in equine colonic mucosa in vitro. Am. J. Vet. Res. 58 (1997) 915-919
4. Fu J.Y., Masferrer J.L., Seibert K., Raz A., and Needleman P. The induction and suppression of prostaglandin synthase (cyclooxygenase) in human monocytes. J. Biol. Chem. 265 (1990) 16737-16740
5. Futaki N., Takahashi S., Yokoyama M., Arai I., Higuchi S., and Otomo S. NS-398, a new anti-inflammatory agent, selectively inhibits prostaglandin G/H synthase/cyclooxygenase (COX-2) activity in vitro. Prostaglandins 47 (1994) 55-59
6. Griffin B.W., Klimko P., Crider J.Y., and Sharif N.A. AL-8810: a novel prostaglandin F2 alpha analog with selective antagonist effects at the prostaglandin F2 alpha (FP) receptor. J. Pharmacol. Exp. Ther. 290 (1999) 1278-1284
7. Harris R.C., and Breyer M.D. Physiological regulation of cyclooxygenase-2 in the kidney. Am. J. Physiol. Renal Physiol. 281 (2001) F1-F11
8. Holzer P., and Holzer-Petsche U. Tachykinins in the gut. Part I. Expression, release and motor function. Pharmacol. Ther. 73 (1997) 173-217
9. Kargman S., Charleson S., Cartwright M., Frank J., Riendeau D., Mancini J., Evans J., and O'Neill G. Characterization of prostaglandin G/H synthase 1 and 2 in rat, dog, monkey, and human gastrointestinal tracts. Gastroenterology 111 (1996) 445-454
10. Keery R.J., and Lumley P. AH6809, a prostaglandin DP-receptor blocking drug on human platelets. Br. J. Pharmacol. 94 (1988) 745-754
11. King J.N., and Gerring E.L. Antagonism of endotoxin-induced disruption of equine bowel motility by flunixin and phenylbutazone. Equine Vet. J. 7 Suppl. (1989) 38-42
12. Kohn C.W., and Muir III W.W. Selected aspects of the clinical pharmacology of visceral analgesics and gut motility modifying drugs in the horse. J. Vet. Int. Med. 2 (1988) 85-91
13. Lee H.M., Kim H.I., Shin Y.K., Lee C.S., Park M., and Song J.H. Diclofenac inhibition of sodium currents in rat dorsal root ganglion neurons. Brain Res. 992 (2003) 120-127
14. MacAllister C.G., Morgan S.J., Borne A.T., and Pollet R.A. Comparison of adverse effects of phenylbutazone, flunixin meglumine, and ketoprofen in horses. J. Am. Vet. Med. Assoc. 202 (1993) 71-77
15. MacKay R.J., French T.W., Nguyen H.T., and Mayhew I.G. Effects of large dose of phenylbutazone administration to horses. Am. J. Vet. Res. 44 (1983) 774-780
16. Mohajer B., and Ma T.Y. Eicosanoids and small intestine. Prostaglandins Other Lipid Mediat. 61 (2000) 125-143
17. Park S.Y., Kim T.H., Kim H.I., Shin Y.K., Lee C.S., Park M., and Song J.H. Celecoxib inhibits Na+ currents in rat dorsal root ganglion neurons. Brain Res. 1148 (2007) 53-61
18. Poli E., Pozzoli C., Coruzzi G., and Bertaccini G. Signal transducing mechanisms coupled to histamine H3 receptors and alpha-2 adrenoceptors in the guinea pig duodenum: possible involvement of N-type Ca++ channels. J. Pharmacol. Exp. Ther. 270 (1994) 788-794
19. Singer I.I., Kawka D.W., Schloemann S., Tessner T., Riehl T., and Stenson W.F. Cyclooxygenase 2 is induced in colonic epithelial cells in inflammatory bowel disease. Gastroenterology 115 (1998) 297-306
20. Smith C.J., Zhang Y., Koboldt C.M., Muhammad J., Zweifel B.S., Shaffer A., Talley J.J., Masferrer J.L., Seibert K., and Isakson P.C. Pharmacological analysis of cyclooxygenase-1 in inflammation. Proc. Natl. Acad. Sci. U S A 95 (1998) 13313-13318
21. Tomlinson J.E., Wilder B.O., Young K.M., and Blikslager A.T. Effects of flunixin meglumine or etodoloc treatment on mucosal recovery of equine jejunum after ischemia. Am. J. Vet. Res. 65 (2004) 761-769
22. 2α on contractility of taenia of the large colon of horses. Am. J. Vet. Res. 60 (1999) 1004-1009
23. Van Hoogmoed L., Snyder J.R., and Harmon F.A. In vitro investigation of the effects of cyclooxygenase-2 inhibitors on contractile activity of the equine dorsal and ventral colon. Am. J. Vet. Res. 11 (2002) 1496-1500
24. Wilson J.E., Chandrasekharan N.V., Westover K.D., Eager K.B., and Simmons D.L. Determination of expression of cyclooxygenase-1 and -2 isozymes in canine tissues and their differential sensitivity to nonsteroidal anti-inflammatory drugs. Am. J. Vet. Res. 65 (2004) 810-818
25. Zimmermann K.C., Sarbia M., Schror K., and Weber A.A. Constitutive cyclooxygenase-2 expression in healthy human and rabbit gastric mucosa. Mol. Pharmacol. 54 (1998) 536-540